Shares of the British-Swedish pharmaceutical company AstraZeneca on the London Stock Exchange (LSE) are down 1.69% after reports of stopping trials of the corona virus vaccine, according to trading platform data. Securities lost 1.69% in value, dropping to 82.07 pounds sterling. The basic index of the British stock market FTSE 100 on Wednesday traded in […]